Evidence map›Paper›PMID 17357785›Full record

ReviewPediatric nephrology (Berlin, Germany)2007

What's new in the aetiopathogenesis of vasculitis?

Paul A Brogan

Open access · bronzeAbstract readReview
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Vasculitis update: pathogenesis and biomarkers.Pediatric nephrology (Berlin, Germany) · 2018
    Review
  6. Article
  7. Vasculitides and the Complement System: a Comprehensive Review.Clinical reviews in allergy & immunology · 2015
    Review
  8. Article
  9. Article
  10. Medium-size-vessel vasculitis.Pediatric nephrology (Berlin, Germany) · 2010
    Review
  11. Small vessel vasculitis.Pediatric nephrology (Berlin, Germany) · 2010
    Review
  12. Review
  13. Systemic vasculitis in childhood.Current rheumatology reports · 2009
    Review
  14. Vasculitis in children.Best practice & research. Clinical rheumatology · 2009
    Review
  15. Article
  16. Review
  17. Atypical clinical course of Henoch-Schonlein purpura.Canadian family physician Medecin de famille canadien · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Paul A BroganDepartment of Rheumatology, Institute of Child Health, Level 6, 30 Guilford St., London, WC1N 1EH, UK. p.brogan@ich.ucl.ac.uk
Institute of Child Health · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cause of the majority of childhood vasculitides is unknown although it is likely that a complex interaction between environmental factors and inherited host responses trigger the disease and determine the vasculitis phenotype. Epidemiological clues continue to implicate infectious triggers in Kawasaki syndrome (KS) and Henoch Schonlein purpura (HSP). Several genetic polymorphisms have now been described in KS and HSP which predispose to disease or predict disease severity. Anti-neutrophil cytoplasmic antibodies (ANCA) are now known to be directly involved in the pathogenesis of vascular injury in ANCA-associated vasculitides, although why some individuals develop ANCA in the first instance is not yet understood. Endothelial injury and repair are active areas of research in vasculitis. It is now possible to track endothelial injury non-invasively in children with vasculitis using surrogate markers of endothelial injury. The vasculogenic pathways involved in vascular repair following vasculitis, including endothelial progenitor cells, are beginning to be studied. It is anticipated that an improved understanding of the aetiopathogenesis of vasculitis in the young will ultimately shape future novel diagnostic and therapeutic approaches and will help us predict which children may develop premature arteriosclerosis in later life.

Indexed as

ChildHumansVasculitis

Identifiers

PMID17357785
PMCPMC7087892
OpenAlexW1981815339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.